Implementation and evaluation of brief depression and anxiety screening in clients contacting a drug and alcohol service

Drug and Alcohol Review

Volumn 31, Issue 3, 2012, Pages 303-310

  Thomas, Anna Christina ^a   Staiger, Petra Karin ^a   Mccabe, Marita ^a  

^a DEAKIN UNIVERSITY   (Australia)

Author keywords

Anxiety; Comorbidity; Depression; Screening; Substance use disorder

Indexed keywords

ADDICTION; ADULT; ANXIETY; ANXIETY DISORDER; ARTICLE; COUNSELING; DEPRESSION; DRUG DEPENDENCE TREATMENT; EVALUATION; FEMALE; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE;

ADULT; ANXIETY; ANXIETY DISORDERS; COUNSELING; DEPRESSION; DEPRESSIVE DISORDER; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 84860210902     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2011.00323.x     Document Type: Article

References (45)

1. Lubman DI, Allen NB, Rogers N, Cementon E, Bonomo Y. The impact of co-occurring mood and anxiety disorders among substance-abusing youth. J Affect Disord 2007;103:105-12.
2. Lubman DI, Hides L, Scaffidi A, Elkins K, Stevens M, Marks R. Implementing mental health screening within a youth alcohol and other drugs service. Ment Health Subst Use 2008;1:254-61.
3. Weaver T, Madden P, Charles V, etal. Comorbidity of substance and mental illness in community mental health and substance misuse services. Br J Psychiatry 2003;183:304-13.
4. Schulte SJ, Meier PS, Stirling J, Berry M. Unrecognised dual diagnosis - a risk factor for dropout of addiction treatment. Ment Health Subst Use 2010;3:94-109.
5. Johnson J. Cost-effectiveness of mental health services for persons with a dual diagnosis. A literature review and the CCMHCP. J Subst Abuse Treat 2000;18:119-27.
6. Baker KD, Lubman DI, Cosgrave EM, etal. Impact of co-occurring substance use on 6month outcomes for young people seeking mental health treatment. Aust NZ J Psychiatry 2007;41:896-902.
7. Chi FW, Satre DD, Weisner C. Chemical dependency patients with cooccurring psychiatric diagnoses: service patterns and 1-year outcomes. Alcohol Clin Exp Res 2006;30:851-9.
8. Kavanagh DJ, Mueser KT, Baker A. Management of comorbidity. In: Teeson M, Proudfoot H, eds. Comorbid mental disorders and substance use disorders: epidemiology, prevention and treatment. Canberra: Department of Health and Ageing, 2003:78-120.
9. Weaver T, Rutter D, Madden P, Ward J, Stimson G, Renton A. Results of a screening survey for co-morbid substance misuse amongst patients in treatment for psychotic disorders: prevalence and service needs in an inner London borough. Soc Psychiatry Psychiatr Epidemiol 2001;36:399-406.
10. Weaver T, Hickman M, Rutter D, Ward J, Stimson G, Renton A. The prevalence and management co-morbid substance misuse and mental illness: results of a screening survey in substance misuse and mental health treatment populations. Drug Alcohol Rev 2001;20:407-16.
11. Cole M, Sacks T. When dual diagnosis means no diagnosis: co-occurring mental illness and problematic drug use in clients of alcohol and drug services in eastern metropolitan Melbourne. Ment Health Subst Use 2008;1:33-43.
12. Baker AL, Kay-Lambkin FJ, Lee N. When less is more: addressing symptoms of mental health problems in drug and alcohol treatment settings. Ment Health Subst Use 2009;2:130-9.
13. Schulte SJ, Meier PS, Stirling J, Berry M. Treatment approaches for dual diagnosis clients in England. Drug Alcohol Rev 2010;27:650-8.
14. Teesson M, Burns L. National comorbidity project. Canberra: Commonwealth Department of Health and Aged Care, 2001.
15. Department of Health. Mental health policy implementation guide: dual diagnosis good practice guide. London: Department of Health, 2002.
16. Centre for Substance Abuse Treatment. Overarching principles to address the needs of persons with co-occurring disorders. COCE Overview Paper 3 DHHS Publication No (SMA) 07-4165.Rockville, MD: Substance Abuse and Mental Health Services, 2007.
17. Victorian Government Department of Human Services. Dual diagnosis key directions and priorities for service development. Melbourne: Victorian Government Department of Human Services, 2007.
18. Aitken C, Wain D, Lubman DI, Hides L, Hellard M. Mental health screening among injecting drug users outside treatment settings - implications for research and health services. Ment Health Subst Use 2008;1:99-103.
19. Kay-Lambkin FJ, Baker A, Lewin TJ. The 'co-morbidity roundabout': a framework to guide assessment and intervention strategies and engineer change among people with co-morbid problems. Drug Alcohol Rev 2004;23:407-23.
20. Magruder KM, Sonne SC, Brady KT, Quello S, Martin RH. Screening for co-occurring mental disorders in drug treatment populations. J Drug Issues 2005;35:593-605.
21. Lee NK, Jenner L. Development of the PsyCheck screening tool: an instrument for detecting common mental health conditions among substance use treatment clients. Ment Health Subst Use 2010;3:56-65.
22. PsyCheck. Fitzroy, Australia: Turning Point Alcohol and Drug Centre. 2011. Available from: (accessed 2 March 2011).
23. Zimmerman M, Sheeran T, Chelminski I, Young D. Screening for psychiatric disorders in outpatients with DSM-IV substance use disorders. J Subst Abuse Treat 2004;26:181-8.
24. Kessler RC, Andrews G, Colpe LJ, etal. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med 2002;32:959-76.
25. Subramaniam G, Harrell P, Huntley E, Tracy M. Beck depression inventory for depression screening in substance-abusing adolescents. J Subst Abuse Treat 2009;37:25-31.
26. Cherry AL, Dillon ME, Hellman CM, Barney LD. The AC-COD screen: rapid detection of people with the co-occurring disorders of substance abuse, mental illness, domestic violence, and trauma. J Dual Diagn 2007;4:35-53.
27. Hides L, Lubman DI, Elkins K, Catania LS, Rogers N. Feasibility and acceptability of a mental health screening tool and training programme in the youth alcohol and other drug (AOD) sector. Drug Alcohol Rev 2007;26:509-15.
28. Cameron J, Lee NK, Harney A. Changes in attitude to, and confidence in, working with comorbidity after training in screening and brief intervention. Ment Health Subst Use 2010;3:124-30.
29. Cameron J, Lee N, Harney A. Translating research into practice: PsyCheck dissemination final report. Melbourne: Turning Point Alcohol and Drug Centre, 2007.
30. Kroenke K, Spitzer RL, Williams JB. The patient health questionnaire-2 validity of a two-item depression screener. Med Care 2003;41:1284-92.
31. Kroenke K, Spitzer RL, Williams JB. Validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-13.
32. Löwe B, Kroenke K, Gräfe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res 2005;58:163-71.
33. Williams LS, Brizendine EJ, Plue L, etal. Performance of the PHQ-9 as a screening tool for depression after stroke. Stroke 2005;36:635-8.
34. Kaner E, Steven A, Cassidy P, Vardy C. Implementation of a model for service delivery and organisation in mental healthcare: a qualitative exploration of service provider views. Health Soc Care Community 2003;11:519-27.
35. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77-101.
36. Smith JA, Osborn M. Interpretative phenomenological analysis. In: Smith JA, ed. Qualitative analysis: a practical guide to research methods. London: Sage Publications, 2003:51-80.
37. Strauss AL, Corbin J. Basics of qualitative research techniques and procedures for developing grounded theory. California: Sage, 1998.
38. Jackson KR, Booth PG, McGuire J, Salmon P. Predictors of starting and remaining in treatment at a specialist alcohol clinic. J Subst Use 2006;11:89-100.
39. de Jonge J, Dormann C. The DISC model: demand-induced strain compensation mechanisms in job stress. In: Dollard MF, Winefield HR, Winefield AH, eds. Occupational stress in the service professions. London: Taylor and Francis, 2003:43-74.
40. Minkoff K, Cline CA. Changing the world: the design and implementation of comprehensive continuous integrated systems of care for individuals with co-occurring disorders. Psychiatr Clin North Am 2004;27:727-43.
41. Lubman DI, Hides L, Elkins K. Developing integrated models of care within the youth alcohol and other drug sector. Australas Psychiatry 2008;16:363-6.
42. Matthews H, Kelly PJ, Dean FP. The dual diagnosis capability of residential addiction treatment centres: priorities and confidence to improve capability following a review process. Drug Alcohol Rev 2011;30:195-9.
43. Hides L, Elkins K, Catania LS, Mathias S, Kay-Lambkin FJ, Lubman D. Feasibility and outcomes of an innovative cognitive-behavioural skill training programme for co-occurring disorders in the youth alcohol and other drug (AOD) sector. Drug Alcohol Rev 2007;26:517-23.
44. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth E, Cori L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci 1974;19:1-15.
45. Minkoff K, Cline CA. Dual diagnosis capability: moving from concept to implementation. J Dual Diagn 2006;2:121-34.